4.7 Review

Roles of ARID1A variations in colorectal cancer: a collaborative review

Related references

Note: Only part of the references are listed.
Article Oncology

The effects of ARID1A mutations on colorectal cancer and associations with PD-L1 expression by stromal cells

Tomohiro Kamori et al.

Summary: In this study utilizing NGS and immunohistochemistry, it was found that ARID1A mutations in CRC are associated with higher mutational burden and increased PD-L1 expression. These findings suggest that mutant ARID1A may serve as a potential biomarker for CRC.

CANCER REPORTS (2022)

Review Biotechnology & Applied Microbiology

Role and potential clinical utility of ARID1A in gastrointestinal malignancy

Ruihua Wang et al.

Summary: ARID1A is a newly discovered tumor suppressor gene that plays a crucial role in various biological behaviors and molecular mechanisms associated with carcinogenesis. Mutations in ARID1A have been increasingly reported in various digestive malignancies, impacting the prognosis of these cancers. The potential of molecular pathologic epidemiology (MPE) to provide insights into environment-tumor-host interactions is also discussed.

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2021)

Article Oncology

Molecular Heterogeneity of High Grade Colorectal Adenocarcinoma

Cristian Perna et al.

Summary: The study characterized the clinicopathological, immunohistochemical, and molecular features of high grade colorectal carcinomas (HG-CRCs), finding that mismatch repair deficiency (MMRd) was a major contributing factor to intertumor and intratumor molecular heterogeneity in HG-CRCs. MMR status conditioned the frequency and clonality of molecular alterations, with distinct molecular differences observed between MMR deficient and MMR proficient tumors.

CANCERS (2021)

Review Biochemistry & Molecular Biology

ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer

Dantong Sun et al.

Summary: ARID1A plays a crucial role in maintaining cellular biological processes, and alterations or loss of its expression may impact therapeutic sensitivity in cancer treatment by regulating multiple signaling pathways leading to resistance to EGFR-TKIs.

MOLECULAR MEDICINE (2021)

Review Oncology

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma

Kazuaki Takahashi et al.

Summary: Ovarian clear cell carcinoma (OCCC) is a histological subtype of ovarian cancer prevalent in Asian countries, with deleterious mutations in SWI/SNF chromatin remodeling genes like ARID1A being common. Therapeutic strategies based on SWI/SNF deficiency, such as gemcitabine-based chemotherapy, synthetic lethal therapy, and immune checkpoint blockade therapy, have the potential to improve patient prognosis by targeting vulnerabilities unique to OCCC.

CANCERS (2021)

Review Oncology

ARID1A Variations in Cholangiocarcinoma: Clinical Significances and Molecular Mechanisms

Shankun Zhao et al.

Summary: ARID1A variation in CCA is common and may serve as a tumor suppressor and prognostic indicator. Multiple molecular mechanisms are involved in the relationship between ARID1A variations and the pathogenesis and pathophysiology of CCA, including disruption of the cell cycle, chromatin remodeling, and DNA hypermethylation.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Characterization of genomic alterations in Chinese colorectal cancer patients

Wei Huang et al.

Summary: This study investigated the different molecular characteristics between left-sided and right-sided colorectal cancer, revealing higher mutation frequencies of TP53 and APC in left-sided colorectal cancer and lower mutation frequency of PIK3CA compared to right-sided colorectal cancer. There were more potential targeted drug therapy opportunities for right-sided colorectal cancer patients, suggesting a better prognosis for them in the Chinese population.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Altered ARID1A expression in colorectal cancer

Mehran Erfani et al.

BMC CANCER (2020)

Review Genetics & Heredity

Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies

Richard C. Centore et al.

TRENDS IN GENETICS (2020)

Article Oncology

The impact of ARID1A mutation on molecular characteristics in colorectal cancer

Ryuma Tokunaga et al.

EUROPEAN JOURNAL OF CANCER (2020)

Review Biochemistry & Molecular Biology

Mutation-Driven Signals of ARID1A and PI3K Pathways in Ovarian Carcinomas: Alteration Is An Opportunity

Pradip De et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Oncology

Cancer Statistics, 2018

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Review Pharmacology & Pharmacy

ARID1A loss in cancer: Towards a mechanistic understanding

Radhika Mathur

PHARMACOLOGY & THERAPEUTICS (2018)

Article Multidisciplinary Sciences

Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells

Changjie Wu et al.

NATURE COMMUNICATIONS (2018)

Article Engineering, Biomedical

Fine-tuning of noise in gene expression with nucleosome remodeling

Melina R. Megaridis et al.

APL BIOENGINEERING (2018)

Article Biochemistry & Molecular Biology

The consensus molecular subtypes of colorectal cancer

Justin Guinney et al.

NATURE MEDICINE (2015)

Article Multidisciplinary Sciences

Comparative Genomic Analysis of Primary and Synchronous Metastatic Colorectal Cancers

Sun Young Lee et al.

PLOS ONE (2014)

Article Gastroenterology & Hepatology

Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer

Xiao-Li Wei et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Oncology

The roles of ARID1A in gynecologic cancer

Tsui-Lien Mao et al.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2013)

Article Biochemistry & Molecular Biology

ARID1a-DNA Interactions Are Required for Promoter Occupancy by SWI/SNF

Ronald L. Chandler et al.

MOLECULAR AND CELLULAR BIOLOGY (2013)

Review Multidisciplinary Sciences

Cancer Genome Landscapes

Bert Vogelstein et al.

SCIENCE (2013)

Review Oncology

ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor?

Jennifer N. Wu et al.

CANCER DISCOVERY (2013)

Article Multidisciplinary Sciences

Comprehensive molecular characterization of human colon and rectal cancer

Donna M. Muzny et al.

NATURE (2012)

Letter Biochemistry & Molecular Biology

Mutations and deletions of ARID1A in breast tumors

S. Cornen et al.

ONCOGENE (2012)

Article Multidisciplinary Sciences

Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer

A. Hunter Shain et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Gastroenterology & Hepatology

Epigenetics and colorectal cancer

Victoria Valinluck Lao et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)

Review Oncology

SWI/SNF nucleosome remodellers and cancer

Boris G. Wilson et al.

NATURE REVIEWS CANCER (2011)

Editorial Material Obstetrics & Gynecology

Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis

[Anonymous]

WOMENS HEALTH (2010)

Article Medicine, General & Internal

ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas

Kimberly C. Wiegand et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Biochemistry & Molecular Biology

Two related ARID family proteins are alternative subunits of human SWI/SNF complexes

XM Wang et al.

BIOCHEMICAL JOURNAL (2004)